Skip to main content
OpenTrials

Clinical trial condition

Genital Neoplasms, Male

Explore clinical trials studying Genital Neoplasms, Male. Study availability and eligibility vary by location and protocol.

5,021 public trials 1,027 recruiting studies
Refine in advanced search Browse all conditions

Genital Neoplasms, Male trial results

Completed

Prostate HistoScanning for the Non-invasive Detection and Staging of Prostate Cancer and Characterization of Prostate Tissues (PHS-02)

NCT01191931

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Bordet Institute Brussels, Brussels Capital, Belgium
  • UZ-Brussel Brussels, Brussels Capital, Belgium
  • Olomouc Hospital Olomouc, Czechia
  • Universitätsklinikum Tübingen Tübingen, Germany
View Trial Details
Completed

Docetaxel and Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases That Progressed on the Docetaxel and Placebo Group of MDA-ID-030008

NCT00084825

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +13 more
Locations
  • Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • M.D. Anderson Cancer Center at University of Texas Houston, Texas, United States
View Trial Details
Completed

Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors

NCT00078845

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +44 more
Locations
  • CCOP - Central Illinois Decatur, Illinois, United States
  • CCOP - Carle Cancer Center Urbana, Illinois, United States
  • CCOP - Wichita Wichita, Kansas, United States
  • Christus St. Frances Cabrini Center for Cancer Care Alexandria, Louisiana, United States
View all 15 locations
View Trial Details
Completed

Docetaxel With or Without Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases

NCT00080678

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +13 more
Locations
  • Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • M.D. Anderson Cancer Center at University of Texas Houston, Texas, United States
View Trial Details
Completed

Evaluation of Safety and Feasibility of OGX-011 in Combination With 2nd-line Chemotherapy in Patients With HRPC

NCT00327340

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • BC Cancer Agency Vancouver, British Columbia, Canada
  • CancerCare Manitoba Winnipeg, Manitoba, Canada
View Trial Details
Completed

Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer

NCT00833248

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Alabama Research Center Birmingham, Alabama, United States
  • Urology Centers of Alabama Homewood, Alabama, United States
  • Alaska Urological Association Anchorage, Alaska, United States
  • Arizona Urologic Specialists Tuscon, Arizona, United States
View all 66 locations
View Trial Details

Related conditions